MedTrace Logo

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

NCT00545558 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2014-08-12

No results posted yet for this study

Summary

The purpose of this study is to measure the effects of anti-HIV drugs on hepatitis C virus (HCV) viral load in people infected with both HCV and HIV.

Conditions

  • Hepatitis C
  • HIV Infections

Interventions

DRUG

Efavirenz

600 mg tablet taken orally daily

DRUG

Emtricitabine/Tenofovir disoproxil fumarate

200 mg emtricitabine/ 300 mg tenofovir disoproxil fumarate tablet taken orally daily

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Kenneth E. Sherman, MD, PhD · Unviersity of Cincinnati

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00545558 on ClinicalTrials.gov